Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10,228 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and effectiveness of granulocyte and monocyte adsorptive apheresis in patients with inflammatory bowel disease in special situations: a multicentre cohort study.
Motoya S, Tanaka H, Shibuya T, Osada T, Yamamoto T, Hongo H, Mizuno C, Saito D, Aoyama N, Kobayashi T, Ito H, Tanida S, Nojima M, Kokuma S, Hosoi E. Motoya S, et al. Among authors: ito h. BMC Gastroenterol. 2019 Nov 21;19(1):196. doi: 10.1186/s12876-019-1110-1. BMC Gastroenterol. 2019. PMID: 31752695 Free PMC article.
Hematologic malignancies in the Japanese patients with inflammatory bowel disease.
Fukata N, Okazaki K, Omiya M, Matsushita M, Watanabe M; Members of the Ministry of Health and Welfare of Japan’s Inflammatory Bowel Diseases Study Group. Fukata N, et al. J Gastroenterol. 2014 Sep;49(9):1299-306. doi: 10.1007/s00535-013-0873-3. Epub 2013 Aug 19. J Gastroenterol. 2014. PMID: 23955181
First trough level of infliximab at week 2 predicts future outcomes of induction therapy in ulcerative colitis-results from a multicenter prospective randomized controlled trial and its post hoc analysis.
Kobayashi T, Suzuki Y, Motoya S, Hirai F, Ogata H, Ito H, Sato N, Ozaki K, Watanabe M, Hibi T. Kobayashi T, et al. Among authors: ito h. J Gastroenterol. 2016 Mar;51(3):241-51. doi: 10.1007/s00535-015-1102-z. Epub 2015 Jul 11. J Gastroenterol. 2016. PMID: 26162647 Free PMC article. Clinical Trial.
Circulating Interleukin 6 and Albumin, and Infliximab Levels Are Good Predictors of Recovering Efficacy After Dose Escalation Infliximab Therapy in Patients with Loss of Response to Treatment for Crohn's Disease: A Prospective Clinical Trial.
Suzuki Y, Matsui T, Ito H, Ashida T, Nakamura S, Motoya S, Matsumoto T, Sato N, Ozaki K, Watanabe M, Hibi T. Suzuki Y, et al. Among authors: ito h. Inflamm Bowel Dis. 2015 Sep;21(9):2114-22. doi: 10.1097/MIB.0000000000000475. Inflamm Bowel Dis. 2015. PMID: 26218144 Clinical Trial.
C-reactive protein is an indicator of serum infliximab level in predicting loss of response in patients with Crohn's disease.
Hibi T, Sakuraba A, Watanabe M, Motoya S, Ito H, Sato N, Yoshinari T, Motegi K, Kinouchi Y, Takazoe M, Suzuki Y, Matsumoto T, Kawakami K, Matsumoto T, Hirata I, Tanaka S, Ashida T, Matsui T. Hibi T, et al. Among authors: ito h. J Gastroenterol. 2014 Feb;49(2):254-62. doi: 10.1007/s00535-013-0807-0. Epub 2013 Apr 20. J Gastroenterol. 2014. PMID: 23604570 Clinical Trial.
Retrieval of serum infliximab level by shortening the maintenance infusion interval is correlated with clinical efficacy in Crohn's disease.
Hibi T, Sakuraba A, Watanabe M, Motoya S, Ito H, Motegi K, Kinouchi Y, Takazoe M, Suzuki Y, Matsumoto T, Kawakami K, Matsumoto T, Hirata I, Tanaka S, Ashida T, Matsui T. Hibi T, et al. Among authors: ito h. Inflamm Bowel Dis. 2012 Aug;18(8):1480-7. doi: 10.1002/ibd.21886. Epub 2011 Oct 10. Inflamm Bowel Dis. 2012. PMID: 21987418
Evidence-based clinical practice guidelines for Crohn's disease, integrated with formal consensus of experts in Japan.
Ueno F, Matsui T, Matsumoto T, Matsuoka K, Watanabe M, Hibi T; Guidelines Project Group of the Research Group of Intractable Inflammatory Bowel Disease subsidized by the Ministry of Health, Labour and Welfare of Japan and the Guidelines Committee of the Japanese Society of Gastroenterology. Ueno F, et al. J Gastroenterol. 2013 Jan;48(1):31-72. doi: 10.1007/s00535-012-0673-1. Epub 2012 Oct 23. J Gastroenterol. 2013. PMID: 23090001 Free PMC article.
Factors associated with treatment outcome, and long-term prognosis of patients with ulcerative colitis undergoing selective depletion of myeloid lineage leucocytes: a prospective multicenter study.
Yokoyama Y, Watanabe K, Ito H, Nishishita M, Sawada K, Okuyama Y, Okazaki K, Fujii H, Nakase H, Masuda T, Fukunaga K, Andoh A, Nakamura S. Yokoyama Y, et al. Among authors: ito h. Cytotherapy. 2015 May;17(5):680-8. doi: 10.1016/j.jcyt.2015.02.007. Epub 2015 Mar 21. Cytotherapy. 2015. PMID: 25804800 Clinical Trial.
10,228 results
You have reached the last available page of results. Please see the User Guide for more information.